BNP PARIBAS FINANCIAL MARKETS - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 48 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$580,000
-14.5%
2,7740.0%0.00%
Q2 2022$678,000
-14.4%
2,7740.0%0.00%
Q1 2022$792,000
-52.9%
2,774
-7.6%
0.00%
Q4 2021$1,681,000
-73.7%
3,001
-52.1%
0.00%
Q3 2021$6,390,000
+46.9%
6,265
+98.8%
0.00%
Q2 2021$4,350,000
-92.3%
3,152
-90.5%
0.00%
Q1 2021$56,250,000
+167.4%
33,088
+95.0%
0.00%
Q4 2020$21,038,000
-22.9%
16,966
-11.7%
0.00%
Q3 2020$27,285,000
+428.5%
19,215
+350.3%
0.00%
Q2 2020$5,163,000
-81.9%
4,267
-82.3%
0.00%
Q1 2020$28,510,000
-16.2%
24,161
+49.8%
0.00%
Q4 2019$34,026,000
+55.3%
16,126
+61.9%
0.00%
Q3 2019$21,910,000
+70577.4%
9,959
+124387.5%
0.00%
Q3 2018$31,000
+14.8%
80.0%0.00%
Q2 2018$27,000
+58.8%
80.0%0.00%
Q1 2018$17,000
+6.2%
80.0%0.00%
Q4 2017$16,000
-56.8%
80.0%0.00%
Q3 2017$37,000
+117.6%
80.0%0.00%
Q2 2017$17,000
-90.7%
8
-86.2%
0.00%
Q1 2017$183,000
-89.3%
58
-91.2%
0.00%
Q4 2016$1,708,000
-81.8%
657
-72.7%
0.00%
Q3 2016$9,359,000
+148.5%
2,406
+71.9%
0.00%
Q2 2016$3,766,000
+67.6%
1,400
+140.5%
0.00%
Q1 2015$2,247,000
-73.0%
582
-61.6%
0.00%
Q3 2014$8,328,000
+143.8%
1,517
+402.3%
0.00%
Q4 2013$3,416,0003020.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Monashee Investment Management LLC 1,652,190$3,817,0002.58%
LINCOLN CAPITAL CORP 62,000$143,0000.13%
Laurion Capital Management LP 1,944,727$4,492,0000.08%
Cedar Wealth Management, LLC 46,395$107,0000.08%
Fosun International Ltd 301,708$709,0000.04%
BCWM, LLC 35,100$811,0000.04%
Engineers Gate Manager LP 170,800$395,0000.03%
Alpine Global Management, LLC 45,211$104,0000.03%
MOORE CAPITAL MANAGEMENT, LP 250,000$578,0000.02%
SECTORAL ASSET MANAGEMENT INC 73,778$170,0000.02%
View complete list of ACELRX PHARMACEUTICALS INC shareholders